Skip to main content
. 2024 Dec 4;27(12):111437. doi: 10.1016/j.isci.2024.111437

Figure 2.

Figure 2

miR-532-3p, miR-1250-5p, and miR-4772-5p serve as survival biomarkers for advanced pCCA patients after HAIC

(A–C) The relationship of miR-532-3p (A)/miR-1250-5p (B)/miR-4772-5p (C) expression with OS.

(D–F) The relationship of miR-532-3p (D)/miR-1250-5p (E)/miR-4772-5p (F) expression with PFS. pCCA perihilar cholangiocarcinoma, HAIC hepatic arterial infusion chemotherapy, OS overall survival, PFS progression-free survival.